Biohit Oyj (CHIX:BIOBVH) FFO


CHIX:BIOBVH Biohit Oyj CHIX:BIOBVH
72 GF Score
Price €2.40
GF Value €2.68
! 3 Warning Signs
View Full Analysis

What is Biohit Oyj FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:BIOBVH
72GF Score
Biohit Oyj CHIX:BIOBVH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biohit Oyj (CHIX:BIOBVH) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.40 is trading 10.4% below its estimated GF Value™ of €2.68.

Key valuation signals for CHIX:BIOBVH:

  • FFO:
  • GF Value™: €2.68 vs. price of €2.40 (10.4% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BIOBVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biohit Oyj Business Description

Other Exchanges 0DRP:UKBIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
72GF Score

Get the complete analysis for CHIX:BIOBVH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.40
Price
€2.68
GF Value